ALTER — Theradiag SA Share Price
0.000.00%
Last trade - 00:00- €16.44m
- €12.36m
- €12.20m
- 78
- 38
- 18
- 38
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 384.85 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.58 | ||
| Price to Tang. Book | 2.26 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.3 | ||
| EV to EBITDA | 9.25 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.4% | ||
| Return on Equity | 4.13% | ||
| Operating Margin | 2.28% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 8.91 | 9.64 | 10.41 | 11.12 | 12.2 | 13.2 | 14.4 | 6.15% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Theradiag SA is a France-based company which develops and markets biological diagnostic tools. The Company develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. TheraDiags product offering consists of tests using a range of techniques (Elisa, rapid tests, immunofluorescence, Dot, immunochemical tests, molecular biology, etc.) as well as a range of automatic devices and solutions for high-speed diagnostics based on Luminexs Multiplex technology. It has also developed a range of theranostic diagnostics commercialized under the Lisa-Tracker brand which provide monitoring of patients treated by anti-TNF monoclonal antibodies. TheraDiag is active in more than 30 countries, as an independent distributor.
Directors
- Pierre-Armand Morgon CHM
- Bertrand de Castelnau CEO (61)
- Vincent Fert DRC
- Gejia Ouyang DRC
- Sylvie Bratel IND
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- December 22nd, 1986
- Public Since
- December 11th, 2012
- No. of Employees
- 61
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 13,050,063
- Address
- 14 Rue Ambroise Croizat, CROISSY-BEAUBOURG, 77183
- Web
- https://www.theradiag.com/
- Phone
- +33 164621012
- Auditors
- Deloitte & Associes
Upcoming Events for ALTER
Similar to ALTER
Abionyx Pharma SA
Euronext - Paris
Abivax SA
Euronext - Paris
Acticor Biotech SA
Euronext - Paris
Adocia SA
Euronext - Paris
Biophytis SA
Euronext - Paris
FAQ
What is the Theradiag SA share price?
As of Today at 18:21 UTC, shares in Theradiag SA are trading at €1.26. This share price information is delayed by 15 minutes.
How has the Theradiag SA share price performed this year?
Shares in Theradiag SA last closed at €1.26 and the price had moved by -44.86% over the past 365 days. In terms of relative price strength the Theradiag SA share price has underperformed the FTSE Global All Cap Index by -50.78% over the past year.
What are the analyst and broker recommendations for Theradiag SA?
The overall consensus recommendation for Theradiag SA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Theradiag SA dividend yield?
Theradiag SA does not currently pay a dividend.
Does Theradiag SA pay a dividend?
Theradiag SA does not currently pay a dividend.
When does Theradiag SA next pay dividends?
Theradiag SA does not currently pay a dividend.
How do I buy Theradiag SA shares?
To buy shares in Theradiag SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Theradiag SA?
As of the previous close price of €1.26, shares in Theradiag SA had a market capitalisation of €16.44m.
Where are Theradiag SA shares listed?
Here are the trading details for Theradiag SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALTER
What kind of share is Theradiag SA?
Based on an overall assessment of its quality, value and momentum Theradiag SA is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Theradiag SA share price forecast for 2023?
The analyst consensus target price for shares in Theradiag SA is €3.80. That is 201.59% above the last closing price of €1.26.
Analysts covering Theradiag SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.04 for the next financial year.
What is the trend in the Theradiag SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Theradiag SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -44.27%.
As of the last closing price of €1.26, shares in Theradiag SA were trading -36.57% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Theradiag SA PE Ratio?
The Theradiag SA PE ratio based on its reported earnings over the past 12 months is 384.85. The shares last closed at €1.26.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Theradiag SA?
Theradiag SA's management team is headed by:
- Pierre-Armand Morgon - CHM
- Bertrand de Castelnau - CEO
- Vincent Fert - DRC
- Gejia Ouyang - DRC
- Sylvie Bratel - IND